2024年11月29日 · Erectile dysfunction is a persistent pattern of being unable to attain and/or maintain a penile erection sufficient for sexual satisfaction. 1 It is a common problem, affecting approximately 30 million men in the United States. 1 Compared to those without diabetes, men with diabetes have an increased risk of developing erectile dysfunction. 2 This article describes how diabetes contributes to ...

PATIENT FACT SHEET Copyright © 2024 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form ...

2024年3月22日 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. A predominant risk factor for type 2 diabetes is being overweight or obese, so weight loss goals while maintaining normal blood sugar levels are very important for some patients.

2024年12月17日 · The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been accepted by the Agency.

2024年6月24日 · A rising trend of hypertensive disorders during pregnancy and associated risk factors among the US pregnant population between 2010 and 2021 underscores a growing public health concern, as evidenced by study findings published in JAMA.. Preeclampsia is a severe pregnancy complication associated with increased risks …

2024年11月22日 · Long-Acting (Basal) Insulin Analogs. The onset of action for long-acting insulin analogs is from 1.5 to 2 hours, followed by a plateau effect for the next few hours and a duration of action between 12 and 24 hours, depending on the insulin administered. 4 Long-acting insulins provide basal insulin that prevents glucose levels from rising during a …

2024年1月12日 · The American Diabetes Association (ADA) has updated its guidelines for the “Standards of Care” for patients with diabetes. The report has been published in Diabetes Care.. In the 2024 update, the ADA focused on patient-centered care, person-first language, and updated screening and treatment approaches based on the latest clinical evidence.

2024年10月8日 · Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are a newer class of medications that are US Food and Drug Administration (FDA)-approved to manage type 2 diabetes and obesity in conjunction with diet and lifestyle changes. 1 GLP-1 agonists affect glycemic control and body weight by increasing insulin production and release in a glucose-dependent manner; decreasing glucagon secretion ...

2024年2月23日 · Survodutide, a glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor dual agonist, reduces body weight in a dose-dependent and tolerable manner, according to study findings published in The Lancet.. To investigate the safety, tolerability, and efficacy of survodutide for weight management, researchers conducted a randomized, double-blind, placebo-controlled, dose-ranging phase 2 trial ...

2024年2月29日 · Approximately 12% of the US population will develop some form of thyroid dysfunction over the course of their lifetime. 1 Older adults (60 years and older) are at an increased risk for changes in thyroid function. 2 Hypothyroidism — reduced production of thyroid hormone — is more common in older individuals than in younger adults. 2 Approximately 1 in 4 nursing home residents have ...